Department of Nutrition, University of Tennessee at Knoxville, Knoxville 37916, USA
College of Food Science and Technology, College of Biomedicine and Health, Huazhong Agricultural University, Wuhan 430070, China
School of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan 430065, China
Department of Public Health, University of Tennessee at Knoxville, Knoxville 37916, USA
†These authors contributed equally to this work.
Show Author Information
Hide Author Information
Highlights
(1) Red Yeast Rice and Treatment Options Lifestyle changes can lower LDL cholesterol levels without increasing the side effects caused by statins.
(2) Future modified red yeast products could be hydrophilic or hydrophobic, thus creating simple daily functional foods that can be adapted to lower blood lipids for a broader range of people.
(3) Contaminants caused by process defects and human error can lead to the mixing of impurities into the product. Which leads to additional risks, even fatal, in the use of red yeast rice, emphasizing the need for upgraded processes and strict quality control.
Graphical Abstract
View original imageDownload original image
The graphical abstract illustrates how red yeast rice (RYR), containing Monacolin K (natural Lovastatin), competitively inhibits HMG-CoA reductase in the liver, blocking cholesterol synthesis and reducing hyperlipidemia. Future modified red yeast rice products could be hydrophilic or hydrophobic, affecting their audience and bioavailability. This product modification aims to create simple daily functional foods that lower blood lipids, reduce side effects like muscle pain, and enhance active ingredient bioavailability for superior effectiveness while minimizing unintended toxic side effects. The image shows RYR in various forms, from raw rice to supplements, emphasizing its potential as a natural cholesterol-lowering agent.
Abstract
Hypercholesterolemia is closely associated with the risk of cardiovascular diseases. Medicinal and dietary approaches are both used to combat it. Red yeast rice (RYR) is a traditional ingredient that has been used for a long time in food preparation. Interestingly, it shows activity to alleviate hypercholesterolemia as a food supplement due to the high content of lovastatin (also known as monacolin K), a statin drug. To gain a comprehensive understanding of RYR and its functions, we have reviewed the current literature from PubMed. This review summarizes the RYR historical use in traditional Chinese medicine and compares it with statins for controlling hypercholesterolemia. In addition, we have also included the side effects of RYR, its impacts on the heart, liver, and muscle, and the limitations of current research. The needs to reduce side effects while providing the same bioavailability and efficacy of RYR for the alleviation of hypercholesterolemia are important for its benefits in health. We believe that more research is needed to thoroughly investigate RYR and find novel compounds with activities to control hypercholesterolemia and help subjects who are sensitive to statin-mediated side effects.
No abstract is available for this article. Click the button above to view the PDF directly.
References
[1]
Fukami, H., Higa, Y., Hisano, T., et al., a review of red yeast rice, a traditional fermented food in Japan and East Asia: its characteristic ingredients and application in the maintenance and improvement of health in lipid metabolism and the circulatory system. Molecules, 2021 , 26: 1619. https://doi.org/10.3390/molecules26061619
WHO TEAM Integrated Health Services, Complementary and Integrative Medicine, WHO traditional medicine strategy: 2014–2023. 2014-2023 ed. 2017, World Health Organization: World Health Organization Library, 76.
[3]
Wang, S., Chen, Y., Wang, R., et al., effectiveness of red yeast rice on carotid atherosclerosis: a systematic review and meta-analysis. Frontiers in Pharmacology, 2022 , 13: 937809. https://doi.org/10.3389/fphar.2022.937809
Huang, Y. Z., Wang, L., Huang, Y. Y. Red yeast rice rich in monacolin k and preparation method of red yeast rice, in Fujian Agriculture and Forestry University, Administration, 2015 , China
Klimek, M., Wang S., Ogunkanmi, A. Safety and efficacy of red yeast rice ( Monascus purpureus) as an alternative therapy for hyperlipidemia. Pharmacy and Therapeutics, 2009, 34: 313–327. https://doi.org/10.1111/j.1365-2710.2008.01010.x
Li, S. Z. Ben Cao Gang Mu, Volume Iii Mountain Herbs, Fragrant Herbs. 1 ed. Vol. 3, 2022 , University of California Press https://doi.org/10.2307/j.ctv2kx8931
Dai, W., Tian Gong Kai Wu: heyday of agriculture and handicraft industry in ancient China, in a new phase of systematic development of scientific theories in china: history of science and technology in china volume 4, Jiang, X., 2021 , Springer Singapore: Singapore. pp. 379–413. https://doi.org/10.1007/978-981-15-7844-1_12
Vohra, L. I., Rizwan, K., Saeed, E., et al. inclisiran adjuvant therapy to statins for the use of hypercholesterolemia: a commentary. Egyptian Heart Journal, 2023 , 75: 60. https://doi.org/10.1186/s43044-023-00389-8
Cicero, A. F. G., Fogacci, F., Stoian, A. P., et al., Red yeast rice for the improvement of lipid profiles in mild-to-moderate hypercholesterolemia: a narrative review. Nutrients, 2023 , 15: 2288. https://doi.org/10.3390/nu15102288
Brandts, J., Tittel, S. R., Bramlage, P., et al. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol in type 1 diabetes and type 2 diabetes: Lipid goal attainment in a large German-Austrian diabetes registry. Diabetes Obes Metab, 2023: 15264. https://doi.org/10.1111/dom.15264
Hill, M. F., Bordoni, B. Hyperlipidemia, in Statpearls. 2023.
[14]
Cao, N. T., Nguyen, N. A., Park, C. M., et al. A novel statin compound from monacolin J produced using cyp102a1-catalyzed regioselective c-hydroxylation. Pharmaceuticals (Basel), 2021, 14: 981. https://doi.org/10.3390/ph14100981
Xiong, Z., Cao, X., Wen, Q., et al. An overview of the bioactivity of monacolin k/lovastatin. Food and Chemical Toxicology, 2019, 131: 110585. https://doi.org/10.1016/j.fct.2019.110585
Chen, G., Chen, W., Xu, J., et al. The current trend and challenges of developing red yeast rice-based food supplements for hypercholesterolemia. Journal of Future Foods, 2023, 3: 312–329. https://doi.org/10.1016/j.jfutfo.2023.03.003
Mirzai, S., Laffin, L. J. Supplements for lipid lowering: what does the evidence show? Current Cardiology Reports, 2023 , 25: 795–805. https://doi.org/10.1007/s11886-023-01903-9
Endo, A., Hasumi, K., Nakamura, T., et al. Dihydromonacolin l and monacolin X, new metabolites which inhibit cholesterol biosynthesis. The Journal of Antibiotics, 1985, 38: 321–327. https://doi.org/10.7164/antibiotics.38.321
Kim, J., Lee H. S., Lee, K. Y. effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea. Cardiovascular Diabetology, 2018 , 17: 155. https://doi.org/10.1186/s12933-018-0799-4https://doi.org/
Verhoeven, V., Van der Auwera, A., Van Gaal, L., et al., Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome? a double blind, placebo controlled randomized trial. BMC Complementary Medicine, 2015 , 15: 52. https://doi.org/10.1186/s12906-015-0576-9
Postolache, T. T., Medoff, D. R., Brown, C. H., et al. Lipophilic vs. hydrophilic statins and psychiatric hospitalizations and emergency room visits in us veterans with schizophrenia and bipolar disorder. Pteridines, 2021, 32: 48–69. https://doi.org/10.1515/pteridines-2020-0028
Shutta, R., Nakatani, D., Sakata, Y., et al. Hydrophilic vs lipophilic statins in diabetic patients-comparison of long-term outcomes after acute myocardial infarction. Circulation Reports, 2020, 2: 280–287. https://doi.org/10.1253/circrep.CR-20-0020
Climent, E., Benaiges D., Pedro-Botet, J. hydrophilic or lipophilic statins? Frontiers in Cardiovascular Medicine, 2021 , 8: 687585. https://doi.org/10.3389/fcvm.2021.687585
Bytyçi, I., Bajraktari, G., Bhatt, D. L., et al., Hydrophilic vs lipophilic statins in coronary artery disease: a meta-analysis of randomized controlled trials. Journal of Clinical LipidologyJournal of Clinical Lipidology, 2017 , 11: 624–637. https://doi.org/10.1016/j.jacl.2017.03.003
Lee, C. L., Chen, W. P., Wang, J. J., et al. A simple and rapid approach for removing citrinin while retaining monacolin k in red mold rice. Journal of Agricultural and Food ChemistryJournal of Agricultural and Food Chemistry, 2007, 55: 11101–11108. https://doi.org/10.1021/jf071640p
Feng, D., Sun, J. G., Sun, R. B., et al., Isoflavones and phytosterols contained in Xuezhikang capsules modulate cholesterol homeostasis in high-fat diet mice. APS (Acta Pharmacologica Sinica ), 2015 , 36: 1462–1472. https://doi.org/10.1038/aps.2015.98
Yang, C. W., Mousa, S. A. The effect of red yeast rice (monascus purpureus) in dyslipidemia and other disorders. Complementary Therapies in Medicine, 2012, 20: 466–474. https://doi.org/10.1016/j.ctim.2012.07.004
Chen, B., Huang, X., Peng, H., et al., Effectiveness and safety of red yeast rice predominated by monacolin K β-hydroxy acid form for hyperlipidemia treatment and management. Journal of Traditional Chinese Medicine, 2022 , 42: 264–271. https://doi.org/10.19852/j.cnki.jtcm.2022.02.007
[30]
Campoy, S., Sierra, S., Suarez, B., et al. Semisynthesis of novel monacolin J derivatives: Hypocholesterolemic and neuroprotective activities. The Journal of Antibiotics, 2010, 63: 499–505. https://doi.org/10.1038/ja.2010.76
Schaars, C. F., Stalenhoef, A. F. Effects of ubiquinone (coenzyme Q10) on myopathy in statin users. Current Opinion in Lipidology, 2008, 19: 553–557. https://doi.org/10.1097/MOL.0b013e3283168ecd
Endo, A., Hasumi K., Negishi, S. Monacolins J and L, new inhibitors of cholesterol biosynthesis produced by monascus ruber. The Journal of Antibiotics, 1985, 38: 420–422. https://doi.org/10.7164/antibiotics.38.420
Elkin, R. G., Lorenz, E. S. feeding laying hens a bioavailable soy sterol mixture fails to enrich their eggs with phytosterols or elicit egg yolk compositional changes. Poultry Science, 2009 , 88: 152–158. https://doi.org/10.3382/ps.2008-00271
Laffin, L. J., Bruemmer, D., Garcia, M., et al., Comparative effects of low-dose rosuvastatin, placebo, and dietary supplements on lipids and inflammatory biomarkers. Journal of the American College of Cardiology, 2023 , 81: 1–12. https://doi.org/10.1016/j.jacc.2022.10.013
Domenech, M., Casas, R., Ruiz-León, A. M., et al. Effects of a novel nutraceutical combination (Aquilea Colesterol®) on the lipid profile and inflammatory biomarkers: a randomized control trial. Nutrients, 2019, 11: 949. https://doi.org/10.3390/nu11050949
Cicero, A. F. G., Fogacci, F., Banach, M. Red yeast rice for hypercholesterolemia. Methodist DeBakey Cardiovascular Journal, 2019, 15: 192–199. https://doi.org/10.14797/mdcj-15-3-192
Dujovne, C.A. Red yeast rice preparations: are they suitable substitutions for statins? The American Journal of Medicine, 2017 , 130: 1148–1150. https://doi.org/10.1016/j.amjmed.2017.05.013
Thompson, P. D., Panza, G., Zaleski, A., et al. Statin-associated side effects. Journal of the American College of Cardiology, 2016, 67: 2395–2410. https://doi.org/10.1016/j.jacc.2016.02.071
Lupo, M. G., Macchi, C., Marchianò, S., et al. Differential effects of red yeast rice, berberis aristata and morus alba extracts on PCSK9 and LDL uptake. Nutrition, Metabolism & Cardiovascular Diseases, 2019, 29: 1245–1253. https://doi.org/10.1016/j.numecd.2019.06.001
Becker, D. J., Gordon, R. Y., Halbert, S. C., et al., Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial. Annals of Internal Medicine, 2009 , 150: 830–839. https://doi.org/10.7326/0003-4819-150-12-200906160-00006
Xu, J., Zhu, L., Xie, Y., et al., Effects of Xuezhikang versus pravastatin on triglyceride level in patients with T2DM and dyslipidemia: study protocol for a multicenter randomized controlled trial. Current Vascular Pharmacology, 2023 , 21: 211–217. https://doi.org/10.2174/1570161121666230328110215
Grieco, A., Miele, L., Pompili, M., et al. Acute hepatitis caused by a natural lipid-lowering product: when “alternative” medicine is no “alternative” at all. Journal of Hepatology, 2009, 50: 1273–1277. https://doi.org/10.1016/j.jhep.2009.02.021
Carter, A. A., Gomes, T., Camacho, X., et al. Risk of incident diabetes among patients treated with statins: population based study. BMJ, 2013, 346: f2610. https://doi.org/10.1136/bmj.f2610
Setnikar, I., Senin P., Rovati, L. C. Antiatherosclerotic efficacy of policosanol, red yeast rice extract and astaxanthin in the rabbit. Arzneimittelforschung, 2005, 55: 312–317. https://doi.org/10.1055/s-0031-1296865
Taylor, B. A., Thompson, P. D. Statin-associated muscle disease: advances in diagnosis and management. Neurotherapeutics, 2018, 15: 1006–1017. https://doi.org/10.1007/s13311-018-0670-z
Pastori, D., Pani, A., Di Rocco, A., et al. Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis. British Journal of Clinical Pharmacology, 2022, 88: 441–451. https://doi.org/10.1111/bcp.14943
Lee, Y., Siddiqui, W. J. Cholesterol levels, in Statpearls. 2023.
[50]
Chen, T. L., Yeh, C. C., Lin, C. S., et al. Effects of red yeast rice prescription ( Lipocol forte) on adverse outcomes of surgery. QJM, 2019, 112: 253–259. https://doi.org/10.1093/qjmed/hcy278
Ma, J., Li, Y., Ye, Q., et al. Constituents of red yeast rice, a traditional Chinese food and medicine. Journal of Agricultural and Food Chemistry, 2000, 48: 5220–5225. https://doi.org/10.1021/jf000338c
Zhuang, P., Wu, F., Mao, L., et al. Egg and cholesterol consumption and mortality from cardiovascular and different causes in the United States: a population-based cohort study. PLOS Medicine, 2021, 18: e1003508. https://doi.org/10.1371/journal.pmed.1003508
Culver, A. L., Ockene, I. S., Balasubramanian, R., et al. Statin use and risk of diabetes mellitus in postmenopausal women in the women's health initiative. JAMA Internal Medicine, 2012, 172: 144–152. https://doi.org/10.1001/archinternmed.2011.625
Gugliucci, A. Triglyceride-rich lipoprotein metabolism: key regulators of their flux. Journal of Clinical Medicine, 2023, 12: 4399. https://doi.org/10.3390/jcm12134399
Feingold, K. R., Obesity and dyslipidemia, in Endotext, Feingold, K.R., Anawalt, B., Blackman, M.R., et al., 2000.
[56]
Fabian, D., Padda I. S., Johal, G. S. Hypoalphalipoproteinemia, in Statpearls. 2023.
[57]
Schade, D. S., Shey L., Eaton, R. P. Cholesterol review: a metabolically important molecule. Endocrine Practice, 2020, 26: 1514–1523. https://doi.org/10.4158/ep-2020-0347
Spence, J. D., Jenkins D. J., Davignon, J. Dietary cholesterol and egg yolks: not for patients at risk of vascular disease. Canadian Journal of Cardiology, 2010, 26: e336–339. https://doi.org/10.1016/s0828-282x(10)70456-6
Trimarco, B., Benvenuti, C., Rozza, F., et al. Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet. Mediterranean Journal of Nutrition and Metabolism, 2011, 4: 133–139. https://doi.org/10.1007/s12349-010-0043-6
Martinez-Martin, F., Corbella, E., Sarasa, I., et al. Effects of treatment with monacolin K, berberine and coenzyme Q10 on lipid metabolism in patients with moderate cardiovascular risk. Semergen, 2022, 48: 403–410. https://doi.org/10.1016/j.semerg.2022.04.005
Moriarty, P. M., Roth, E. M., Karns, A., et al. Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study. Journal of Clinical Lipidology, 2014, 8: 568–575. https://doi.org/10.1016/j.jacl.2014.09.002
Ruscica, M., Pavanello, C., Gandini, S., et al. Nutraceutical approach for the management of cardiovascular risk-a combination containing the probiotic Bifidobacterium longum BB536 and red yeast rice extract: results from a randomized, double-blind, placebo-controlled study. Nutrition Journal, 2019, 18: 13. https://doi.org/10.1186/s12937-019-0438-2
Derosa, G., Bonaventura, A., Bianchi, L., et al. A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, silybum marianum and octasonol on lipid profile, endothelial and inflammatory parameters. Journal of Biological Regulators and Homeostatic Agents, 2014, 28: 317–324.
Zhao, S. P., Liu, L., Cheng, Y. C., et al. Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease. Circulation, 2004, 110: 915–920. https://doi.org/10.1161/01.Cir.0000139985.81163.Ce
Freeman, D. J., Norrie, J., Sattar, N., et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the west of scotland coronary prevention study. Circulation, 2001, 103: 357–362. https://doi.org/10.1161/01.cir.103.3.357
Hori, M., Hasegawa, Y., Hayashi, Y., et al. Acute cholesterol-lowering effect of exendin-4 in Ldlr−/− and C57BL/6J mice. Journal of Atherosclerosis and Thrombosis, 2023, 30: 74–86. https://doi.org/10.5551/jat.60921https://doi.org/
Statins, in Livertox: clinical and research information on drug-induced liver injury. 2012, National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda (MD).
[70]
Browning, J. D. Statins and hepatic steatosis: perspectives from the dallas heart study. Hepatology, 2006, 44: 466–471. https://doi.org/10.1002/hep.21248
Guardamagna, O., Abello, F., Baracco, V., et al. The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols. Nutrition, Metabolism & Cardiovascular Diseases, 2011, 21: 424–429. https://doi.org/10.1016/j.numecd.2009.10.015
Fogacci, F., Banach, M., Mikhailidis, D. P., et al., Safety of red yeast rice supplementation: a systematic review and meta-analysis of randomized controlled trials. Pharmacological Research, 2019 , 143: 1–16. https://doi.org/10.1016/j.phrs.2019.02.028
Duncan, A. J., Hargreaves, I. P., Damian, M. S., et al., Decreased ubiquinone availability and impaired mitochondrial cytochrome oxidase activity associated with statin treatment. Toxicology Mechanisms and Methods, 2009 , 19: 44–50. https://doi.org/10.1080/15376510802305047
Cicero, A. F., Colletti, A., Fogacci, F., et al. Effects of a combined nutraceutical on lipid pattern, glucose metabolism and inflammatory parameters in moderately hypercholesterolemic subjects: a double-blind, cross-over, randomized clinical trial. High Blood Pressure & Cardiovascular Prevention, 2017, 24: 13–18. https://doi.org/10.1007/s40292-016-0163-2https://doi.org/
Li, M., He, Q., Chen, Y., et al. Xuezhikang capsule for type 2 diabetes with hyperlipemia: a systematic review and meta-analysis of randomized clinical trails. Evidence-Based Complementary and Alternative Medicine, 2015, 2015: 468520. https://doi.org/10.1155/2015/468520
Gan, C., Guan, Y., Yang, H. Preparation method of highly soluble water-soluble monascus pigment, in Google patents, Administration, 2008.
[77]
Wang, T. J., Lien, A. S., Chen, J. L., et al. A randomized clinical efficacy trial of red yeast rice ( Monascus pilosus) against hyperlipidemia. The American Journal of Chinese Medicine, 2019, 47: 323–335. https://doi.org/10.1142/s0192415x19500150
Corcos, L., Le Jossic-Corcos, C. Statins: perspectives in cancer therapeutics. Digestive and Liver Disease, 2013, 45: 795–802. https://doi.org/10.1016/j.dld.2013.02.002
Lee, I. T., Lee, W. J., Tsai, C. M., et al. Combined extractives of red yeast rice, bitter gourd, chlorella, soy protein, and licorice improve total cholesterol, low-density lipoprotein cholesterol, and triglyceride in subjects with metabolic syndrome. Nutrition Research, 2012, 32: 85–92. https://doi.org/10.1016/j.nutres.2011.12.011
Tshongo Muhindo, C., Ahn, S. A., Rousseau, M. F., et al. Efficacy and safety of a combination of red yeast rice and olive extract in hypercholesterolemic patients with and without statin-associated myalgia. Complementary Therapies in Medicine, 2017, 35: 140–144. https://doi.org/10.1016/j.ctim.2017.10.014
Qu, H., Guo, M., Chai, H., et al. Effects of coenzyme q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials. Journal of the American Heart Association, 2018, 7: e009835. https://doi.org/10.1161/jaha.118.009835https://doi.org/
Herrett, E., Williamson, E., Brack, K., et al. Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials. BMJ, 2021, 372: n135. https://doi.org/10.1136/bmj.n135
Tokuhisa, H., Murai, H., Okabe, Y., et al. Differential effects of lipophilic and hydrophilic statins on muscle sympathetic nerve activity in heart failure with preserved left ventricular ejection fraction. Autonomic Neuroscience, 2018, 213: 8–14. https://doi.org/10.1016/j.autneu.2018.04.006
Hlatky, M. A., Gonzalez, P. E., Manson, J. E., et al. Statin-associated muscle symptoms among new statin users randomly assigned to vitamin d or placebo. JAMA Cardiology, 2023, 8: 74–80. https://doi.org/10.1001/jamacardio.2022.4250
Kageyama, Y. 5 dead and over 100 hospitalized from recalled Japanese health supplements. 2024, Associated Press.
[86]
Ding, M., Si, D., Zhang, W., et al. Red yeast rice repairs kidney damage and reduces inflammatory transcription factors in rat models of hyperlipidemia. Experimental and Therapeutic Medicine, 2014, 8: 1737–1744. https://doi.org/10.3892/etm.2014.2035
Peterslund, P., Christensen, H. D., Urbahnke, J., et al. Red yeast rice as the presumed cause of acute kidney and liver failure. Ugeskrift for Læger, 2019 , 181.
[88]
Minamizuka, T., Koshizaka, M., Shoji, M., et al. Low dose red yeast rice with monacolin k lowers LDL cholesterol and blood pressure in Japanese with mild dyslipidemia: a multicenter, randomized trial. Asia Pacific Journal of Clinical Nutrition, 2021, 30: 424–435. https://doi.org/10.6133/apjcn.202109_30(3).0009
Iwatsuki, M., Takada, S., Mori, M., et al. In vitro and in vivo antimalarial activity of puberulic acid and its new analogs, viticolins a-c, produced by Penicillium sp. Fki-4410. The Journal of Antibiotics, 2011, 64: 183–188. https://doi.org/10.1038/ja.2010.124
Prasad, G. V., Wong, T., Meliton, G., et al. Rhabdomyolysis due to red yeast rice ( Monascus purpureus) in a renal transplant recipient. Transplantation, 2002, 74: 1200–1201. https://doi.org/10.1097/00007890-200210270-00028
Sattar, N., Preiss, D., Murray, H. M., et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet, 2010, 375: 735–742. https://doi.org/10.1016/s0140-6736(09)61965-6
Cicero, A. F., Morbini, M., Rosticci, M., et al. Middle-term dietary supplementation with red yeast rice plus coenzyme Q10 improves lipid pattern, endothelial reactivity and arterial stiffness in moderately hypercholesterolemic subjects. Annals of Nutrition and Metabolism, 2016, 68: 213–219. https://doi.org/10.1159/000445359
Sartore, G., Burlina, S., Ragazzi, E., et al., Mediterranean diet and red yeast rice supplementation for the management of hyperlipidemia in statin-intolerant patients with or without type 2 diabetes. Evidence-Based Complementary and Alternative Medicine, 2013 , 2013: 743473. https://doi.org/10.1155/2013/743473
Feuerstein, J. S., Bjerke, W. S. Powdered red yeast rice and plant stanols and sterols to lower cholesterol. Journal of Dietary Supplements, 2012, 9: 110–115. https://doi.org/10.3109/19390211.2012.682645
Iskandar, I., Harahap, Y., Wijayanti, T. R., et al. Efficacy and tolerability of a nutraceutical combination of red yeast rice, guggulipid, and chromium picolinate evaluated in a randomized, placebo-controlled, double-blind study. Complementary Therapies in Medicine, 2020, 48: 102282. https://doi.org/10.1016/j.ctim.2019.102282
Becker, D. J., French, B., Morris, P. B., et al. Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial. American Heart Journal, 2013, 166: 187–196. https://doi.org/10.1016/j.ahj.2013.03.019
Hermans, N., Van der Auwera, A., Breynaert, A., et al. A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, oxldl and LP-PLA(2), in subjects with metabolic syndrome: a randomised, double-blind, placebo-controlled trial. Trials, 2017, 18: 302. https://doi.org/10.1186/s13063-017-2058-5
Cicolari, S., Pavanello, C., Olmastroni, E., et al. Interactions of oxysterols with atherosclerosis biomarkers in subjects with moderate hypercholesterolemia and effects of a nutraceutical combination ( Bifidobacterium longum BB536, red yeast rice extract) (randomized, double-blind, placebo-controlled study). Nutrients, 2021, 13: 427. https://doi.org/10.3390/nu13020427
Cicero, A. F., Derosa, G., Parini, A., et al. Red yeast rice improves lipid pattern, high-sensitivity c-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic italian subjects. Nutrition Research, 2013, 33: 622–628. https://doi.org/10.1016/j.nutres.2013.05.015
Lee, C. Y., Yu, M. C., Perng, W. T., et al. No additional cholesterol-lowering effect observed in the combined treatment of red yeast rice and lactobacillus casei in hyperlipidemic patients: a double-blind randomized controlled clinical trial. Chinese Journal of Integrative Medicine, 2017, 23: 581–588. https://doi.org/10.1007/s11655-016-2530-1
Heber, D., Yip, I., Ashley, J. M., et al. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. The American Journal of Clinical Nutrition, 1999, 69: 231–236. https://doi.org/10.1093/ajcn/69.2.231
Lee, C. Y., Jan, M. S., Yu, M. C., et al., Relationship between adiponectin and leptin, and blood lipids in hyperlipidemia patients treated with red yeast rice. Research in Complementary Medicine, 2013 , 20: 197–203. https://doi.org/10.1159/000351455
Spigoni, V., Aldigeri, R., Antonini, M., et al. Effects of a new nutraceutical formulation (berberine, red yeast rice and chitosan) on non-HDL cholesterol levels in individuals with dyslipidemia: results from a randomized, double blind, placebo-controlled study. International Journal of Molecular Sciences, 2017, 18: 1498. https://doi.org/10.3390/ijms18071498
Corrao, G., Ibrahim, B., Nicotra, F., et al. Statins and the risk of diabetes: evidence from a large population-based cohort study. Diabetes Care, 2014, 37: 2225–2232. https://doi.org/10.2337/dc13-2215
Chen, T. L., Lin, C. S., Lin, J. A., et al. Evaluating risk of incident diabetes between patients who used lovastatin and red yeast rice prescriptions ( Lipocol forte): a retrospective cohort study based on a real-world database. Diabetes, Metabolic Syndrome and Obesity, 2020, 13: 89–98. https://doi.org/10.2147/dmso.S223833
Ito, Y., Kawasaki, M., Yokoyama, H., et al. Different effects of pravastatin and cerivastatin on the media of the carotid arteries as assessed by integrated backscatter ultrasound. Circulation Journal, 2004, 68: 784–790. https://doi.org/10.1253/circj.68.784
Pravastatin Multicenter Study Group II. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. JAMA Internal Medicine, 1993, 153: 1321–1329.
Ma G-D, Hu X-G, Xu J-H, et al. Future of red yeast rice: a promising and safer natural approach for daily management of hypercholesterolemia. Food & Medicine Homology, 2025,https://doi.org/10.26599/FMH.2026.9420092